Taperdex 7-day
Product Images NDC 42195-270

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Taperdex 7-day (NDC 42195-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Digram (Strut 6)

Chemical structure of the active ingredient in TaperDex 7-day by Xspire Pharma, Llc, showing the molecular formula arrangement with distinct rings and functional groups.*

FDA Label Image

Taperd2 (Taperdnw 7)

TaperDex 7-day (dexamethasone 1.5 mg) Tablets packaging label showing a 27-tablet count for tapered oral steroid therapy. The label includes dosing instructions, a 7-day tapering schedule chart, the Xspire Pharma logo, NDC 42195-0270-07, and a barcode. Tablets are Rx only and the label emphasizes storage instructions and dosage guidelines.*

FDA Label Image

Taperd1 (Taperold 7)

Label and packaging images for TaperDex 7-day tablets, containing dexamethasone 1.5 mg. The label indicates 27 tablets for a 7-day tapered oral steroid therapy, with clear dosage instructions. The labeler is Xspire Pharma, Llc, Ridge-land, MS. The packaging includes a dosage chart for AM and PM doses across 7 days and warnings about prescription use and medication storage temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.